U.S. Leading Ophthalmic Diseases Markets
U.S. Leading Ophthalmic Diseases Markets
RELEASE DATE
20-May-2002
20-May-2002
REGION
North America
North America
Research Code: A172-01-00-00-00
SKU: HC00825-NA-MR_04522
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC00825-NA-MR_04522
Description
The leading ophthalmic diseases in the U.S. are glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), and cataracts. The market opportunity in these areas is large and untapped, because a significant portion of the patient base is undiagnosed, and there is still a lack of a curative treatment for all of these diseases. This report summarizes, in detail, the demand and business opportunities in each of the four diseases, as well as the research projects ongoing for developing innovative therapies. Altogether, this report gives an excellent overview of what can be expected to happen in the near future in the field of the most important ophthalmic diseases.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Introduction
- Market Drivers
- Market Restraints
Forecasts and Trends
- Demand Analysis
- Market and Technology Trends
Frost & Sullivan Market Engineering Awards
- Brand Awareness Development Award- Bausch & Lomb
- Technology Innovation Award - Oculex Pharmaceuticals
- Business Development Strategy Award - Alcon Laboratories
- Market Penetration Award - Merck & Co.
- Product Launch Strategy Award - Novartis Ophthalmics
Overview
Forecasts and Trends
Competitive Analysis
- Introduction
- Glaucoma Treatments
- Market Drivers
- Market Restraints
- Challenges
- Market Engineering Analysis
Strategic Recommendations
- Revenue Forecasts
- Revenue Forecast Assumptions
- Demand Analysis
- Market and Technology Trends
- Research Directions
- Pricing Trends
Overview
Market and Technology Trends
Overview
Market and Technology Trends
Overview
Market and Technology Trends
Cataract
Demography
Popular Topics
The leading ophthalmic diseases in the U.S. are glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), and cataracts. The market opportunity in these areas is large and untapped, because a significant portion of the patient base is undiagnosed, and there is still a lack of a curative treatment for all of these diseases. This report summarizes, in detail, the demand and business opportunities in each of the four diseases, as well as the research projects ongoing for developing innovative therapies. Altogether, this report gives an excellent overview of what can be expected to happen in the near future in the field of the most important ophthalmic diseases.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A172-01-00-00-00 |
Is Prebook | No |